HAL (France)open access
Longitudinal clinical response to Janus kinase inhibitors in systemic sclerosis: a real-life multicentric study across multiple clinical domains
1, JAK inhibitor, Scleroderma, Safety, Efficacy, 0, Systemic sclerosis
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 288188
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.